FDA: 24 Months, Nearly 3,000 Transvaginal Mesh Complication Reports

The Food and Drug Administration (FDA) conducted an adverse event report for a two-year period beginning in early 2008. During that time, nearly 3,000 patients reported complications associated with their pelvic organ prolapse (POP) and stress urinary incontinence (SUI) surgeries. Based on this unusually extensive reporting, the FDA concluded that transvaginal mesh complications were distressingly common and advised that patients and health care providers be aware of the risks of these medical devices.


Have you suffered pain and discomfort as a result of your invasive SUI or POP procedure? Your pain may be the result of a device manufacturer’s carelessness. Find out if you have a viable legal claim by contacting the professionals and attorneys at Fears Nachawati immediately. With years of experience and dedicated expertise, we’re ready to help you! For a free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

Trackbacks (0) Links to blogs that reference this article Trackback URL
Comments (0) Read through and enter the discussion with the form at the end
Post A Comment / Question Use this form to add a comment to this entry.

Remember personal info?